Show simple item record

dc.creatorSpyridaki, M. H.en
dc.creatorLyris, E.en
dc.creatorGeorgoulakis, I.en
dc.creatorKouretas, D.en
dc.creatorKonstantinidou, M.en
dc.creatorGeorgakopoulos, C. G.en
dc.date.accessioned2015-11-23T10:48:20Z
dc.date.available2015-11-23T10:48:20Z
dc.date.issued2004
dc.identifier10.1016/j.jpba.2003.12.007
dc.identifier.issn0731-7085
dc.identifier.urihttp://hdl.handle.net/11615/33305
dc.description.abstractXylazine and its main metabolites were detected in equine urine after a single-dose intravenous administration of 0.98 and 1.01 mg/kg body weight xylazine, respectively, in two horses, in order to be used for equine doping control routine analysis. The urine levels of the parent drug and its metabolites were determined using gas chromatography-mass spectrometry (GC-MS). Xylazine is metabolised rapidly, down to a concentration level of about 1.0 mug/ml after 1-3 h administration. Seven metabolites were identified in urine. 4-Hydroxy-xylazine, the major metabolite, could be traced for 25 It and it is regarded as the long-term metabolite of xylazine in horse. 2,6-Dimethylaniline was, for the first time, reported as metabolite in equine. (C) 2003 Elsevier B.V. All rights reserved.en
dc.sourceJournal of Pharmaceutical and Biomedical Analysisen
dc.source.uri<Go to ISI>://WOS:000220699600012
dc.subjectxylazineen
dc.subjectxylazine metabolitesen
dc.subjectequine urineen
dc.subjectGC-MSen
dc.subjectLIQUID-CHROMATOGRAPHYen
dc.subjectHORSEen
dc.subjectChemistry, Analyticalen
dc.subjectPharmacology & Pharmacyen
dc.titleDetermination of xylazine and its metabolites by GC-MS in equine urine for doping analysisen
dc.typejournalArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record